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Abstract
The influence of smoking on the levels of several biomarkers of oxidative stress, antioxidant status and redox
status have been investigated in 48 healthy men with a mean age of 25 y. The biomarkers of oxidative stress are the
reactive oxygen metabolytes (ROM) and the total oxidant status (TOS). The biomarkers for the antioxidant activity
are the biological antioxidant potential (BAP), the ferric reducing ability of plasma (FRAP), the total antioxidant status
(TAS), the assay for the defense against the oxidation by hypochlorous acid (OXY) and uric acid (UA). The total thiol
levels (TTL) have been measured as a biomarker for the redox status.
The average concentration of ROM was 14% higher in smokers compared with non-smokers (p<0.05), whereas
TOS was 4.9% higher (not statistically significant).The average concentrations of BAP, FRAP and TAS decreased
with smoking with 3.6 (p<0.025), 3.6 (non-significant) and 6.1% (p<0.025), respectively. Alsouric acid, the main
antioxidant in serum and a major contributor to the antioxidant status in serum, decreased by 10.6 % (p<0.025) in
smokers. The biomarker of the redox status (TTL) was not influenced by smoking.
From these results, it is concluded that in epidemiological studies the effect of smoking should be taken in
account when using oxidative stress and antioxidant biomarkers.
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Introduction
Biomarker studies of oxidative stress and antioxidant status are
frequently used to determine the risk of developing chronic diseases,
such as cancer, cardiovascular diseases or cognitive decline. The
influence of lifestyle factors can have a substantial effect on the
biomarker concentrations and therefore these factors, including
smoking, should be taken into account in biomarker-based studies [1].
During smoking, free radicals are formed that can activate
inflammatory cells which generate high levels of reactive oxygen
metabolites [2,3]. Therefore smokers are subjected to an increased
oxidative stress situation, which can result in an imbalance between
oxidants and antioxidants [4]. As a result, biomarkers of oxidative
stress, antioxidant and redox status will be influenced by smoking
behavior [5,6].
In the present study the influence of smoking on biomarkers of
both oxidative stress, redox and antioxidant status was investigated in
a healthy male population.
Materials and Methods
The 48 human volunteers (all men) were selected from 50 healthy
candidates for military service. According to a smoking questionnaire,
23 volunteers were smokers and 25 volunteers were non-smokers. The
mean age of the smokers was 25.5 y and of the non-smokers 24.9 y.
The smokers smoked 10-20 cigarettes/day for more than 5 years,
whereas the non-smokers did not smoke for at least 5 years. Two
volunteers did not have a clear statement about the smoking status.
Fasting blood samples were drawn from the antecubital vein. Blood
samples were processedby centrifugation and aliquots of serum were
stored at -70°C until analysis.
The study was performed and approved under ethical guidance of
Dr. Dusan Stojanovik as documented by the Command of the Military
Medical Center, Ministry of Defense of the Republic of Macedonia,
and described in Document N no. 04-7/18 from the Army Mail
2990/80, Skopje, Republic of Macedonia.
The ROM assay
The Reactive Oxygen Metabolites (ROM) were measured by the kit
(dROMs) from Diacron (Grosseto, Italy). The method measures the
concentration of hydroperoxides which are present in the serum
sample. The method is based on the principle that, in an acidic
solution (pH=4.8), iron is released from transferrin and is available to
catalyze the reaction of hydroperoxides to alkoxyl and peroxyl radicals,
which further react with chromogen N,N-diethyl-p-
phenylenediamine. Upon oxidation, the chromogen is transformed in
red colored cation which is measured at 505 nm. The results of the test
are expressed in CARR U (Carratelli Units). Each CARR U
corresponds to 0.08 mg H2O2/100 mL sample. The reagents from the
kit of Diacron were adjusted for use on the autoanalyzer LX20-Pro
from Beckman-Coulter (Woerden, the Netherlands).
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The TOS assay
The Total Oxidant Status (TOS) was measured by the kit from
RelAssay Diagnostics (Gaziantep, Turkey). The method is based on the
principle that oxidants which are present in the sample can oxidize the
ferrous ions to ferric ions [7]. Then, in an acidic medium, the ferric
ions form a colored complex with a chromogen. The intensity of the
color was measured at 530 nm. The assay was calibrated with H2O2,
and the results of the assay are expressed in μmol H2O2 Eq/L. The
assay was performed in microtiter plates.
The BAP assay
For measurement of the Biological Antioxidant Potential (BAP) the
kit from Diacron (Grosseto, Italy) was used. The assay is based on the
decrease in absorption when Fe3+ ions that bind to a thiocyanate-
derived substrate, are reduced to Fe2+. The absorbance was measuredat
505 nm, and the amount of reduced ferric ions can be calculated. The
results of the assay are expressed as μ Eq ferric ions reducing
antioxidants per L of sample. The kit from Diacron was adjusted for
the use on the auto-analyzer LX20-Pro from Beckman-Coulter
(Woerden, the Netherlands).
The FRAP assay
The measurement of the Ferric Reducing Ability of Plasma (FRAP)
was done by the assay based on the method of Benzie and Strain [8],
slightly modified. The method is based on the principle of reduction of
ferric-tripyridyltriazine complex to ferrous form, upon which an
intense blue color develops, and the change of absorbance is measured
at 593 nm (kinetic method). We have measured the ferric reducing
ability of plasma in a microplate format, by the end-point approach.
The absorbance was measured on a Chem Well analyzer (Palm City,
FL, USA) at 600 nm, against reagent blank. Standards of 500, 1000 and
2000 μmol/L FeSO4were used for calibration of the assay. The results
of the test are expressed as μmol/L FeSO4.
The TAS assay
The Total Antioxidant Status (TAS) was measured by the test kit
from RelAssay Diagnostics (Gaziantep, Turkey). The method is based
on the reduction of colored ABTS radical by antioxidants that are
present in the sample. The absorbance is measured at 660 nm. The kit
from RelAssay was adjusted for the use on the auto-analyzer LX20-Pro
from Beckman-Coulter (Woerden, the Netherlands).
The TTL assay
The Total Thiols Levels (TTL) were measured using also the reagent
kit from RelAssay Diagnostics (Gaziantep, Turkey). The method is
based on the reaction of plasma thiols with 5,5’-dithiobis-(2-
nitrobenzoic acid), resulting in an increase in absorption at 412 nm.
The results of the test are expressed in μmol/L. The kit from RelAssay
was adjusted for the use on the auto-analyzer LX20-Pro from
Beckman-Coulter (Woerden, the Netherlands).
The OXY assay
The OXY-Adsorbent test from Diacron (Grosseto, Italy) measures
the ability to oppose against oxidation, induced by hypochlorous acid.
Unreacted HClO radicals further react with the chromogen solution of
N,N-diethyl-p-phenylenediamine and forms a colored complex, which
is measured at 505 nm. The results of the test are expressed as μmol
HClO/mL. The kit from Diacron was adjusted for the use on the auto-
analyzer LX20-Pro from Beckman-Coulter (Woerden, the
Netherlands).
The uric acid assay
Uric acid (UA) was measured by the enzymatic method using
uricase and was performed on an auto-analyzer LX20-Pro from
Beckman-Coulter (Woerden, the Netherlands) with a dedicated kit for
uric acid.
Statistics
The results of all measurements are expressed as mean ± standard
deviation. The distribution of data was assessed with Kolmogorov-
Smirnov test, using Statistica-7 software.
Because all data sets were normally distributed, further analysis was
performed with Student’s t-test, two-sample equal variance or two-
sample unequal variance, as appropriate, using Microsoft Excel. The
differences between groups were considered as statistically significant
if p<0.05.
The coefficients of correlation between the assays were calculated
with Microsoft Excel. The statistical significance of the coefficients of
correlation was assessed according to the number of subjects within
the group, using a common statistical table [9]. The correlation
coefficient was considered as statistically significant when p<0.05.
Results
In this human volunteers study two assays for oxidative stress,
ROM and TOS were used. Both biomarkers show a higher level in the
serum of smokers of 13.8 and 4.9 % for ROM and TOS, respectively, as
shown in Figure 1. The increase of ROM is statistically significant
(p<0.05). The large variability of the TOS assay prohibits a statistical
significance.
Figure 1: The effect of smoking on several biomarkers in human
serum of non-smokers (grey bars) and smokers (black bars): ROM
(CARR U), TOS (µmol H2O2Eq/L), BAP (µEq/L), FRAP (µmol/L),
TAS (mmol/L), TTL (µmol/L), OXY (µmol HClO/mL) and UA
(µmol/L). The concentrations of TOS and TAS were multiplied by a
factor 200 and 300, respectively, and the concentration of BAP and
FRAP were divided by a factor 5 and 3, respectively, to fit in the
figure. Statistics: * p<0.05 and ** p<0.025.
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Three of the biomarkers of the antioxidant status (BAP, FRAP and
TAS) show lower levels in smokers but by a small percentage only,
ranging between 3.6 to 6.1 % (Table 1). The decreases of BAP and TAS
were statistically significant with p-values of 0.016 and 0.012,
respectively.
In the OXY test the same concentrations were observed between the
smokers and non-smokers.
The total thiol assay reflects the redox status. In smokers, this
biomarker was 4.8 % lower compared with non-smokers, but this
decrease was not statistically significant.
In addition, UA was determined because it is the most important
contributor to the total antioxidant status. UA decreased with 10.6 %
in smokers with a statistically significant p-value of 0.017 (Table 1).
Biomarker % Change P-value
ROM 13.8 0.030*
TOS 4.92 0.671
BAP -3.62 0.016**
FRAP -3.56 0.282
TAS -6.13 0.012**
TTL -4.78 0.141
OXY 0.70 0.890
UA -10.61 0.017**
*p<0.05; **p<0.025.
Table 1: The mean percentage of change in sera of smoking human
volunteers compared with non-smoking volunteers.
Non-
smokers
(N=25)
BAP FRAP ROM TAS TOS TTL UA OXY
BAP 1.00
FRAP 0.17 1.00
ROM -0.18 0.09 1.00
TAS 0.45* 0.84** 0.01 1.00
TOS -0.36 0.18 0.10 -0.12 1.00
TTL 0.47* -0.15 -0.03 0.17 -0.21 1.00
URIC 0.30 0.86** -0.01 0.94** -0.08 -0.01 1.00
OXY 0.13 0.36 -0.03 0.48* -0.22 -0.01 0.56** 1.00
Smokers
(N=23)
BAP FRAP ROM TAS TOS TTL UA OXY
BAP 1.00
FRAP -0.19 1.00
ROM 0.18 0.13 1.00
TAS 0.02 0.80** -0.14 1.00
TOS 0.04 -0.05 0.12 -0.23 1.00
TTL 0.50* 0.20 -0.29 0.30 0.19 1.00
URIC -0.15 0.89** 0.07 0.89** -0.22 0.17 1.00
OXY -0.26 -0.05 0.00 -0.19 0.14 -0.06 -0.08 1.00
*p<0.05; **p<0.01.
Table 2: Coefficients of correlation between the assays as performed on
serum samples of non-smokers and smokers. For non-smokers the
threshold value for a statistical significant correlation of p<0.05 is
r=0.396, and for a statistical significance of p<0.01 this value is 0.505.
For smokers these threshold values are r=0.413 and r=0.526,
respectively.
The correlations between the various biomarkers of oxidant and
antioxidant status are different for smokers and non-smokers. In Table
2 the correlations are shown between all biomarker assays presented in
this study. The statistically significant correlations between BAP and
TAS, as well as between OXY and TAS and between OXY and UA
within the group of non-smokers are not present in the smokers
group.
Discussion
In biomarker studies a number of modifying factors have to be
taken into account such as storage conditions [10], the influence of
post-prandial effects [11], circadian rhythm [12,13], body mass index
[14] and the smoking behavior. In the present study the influence of
smoking on number biomarkers of oxidative stress was investigated in
healthy young men. As biomarkers of oxidative stress, ROM and TOS
were measured, for the antioxidant activity BAP, FRAP, TAS, OXY
and UA. TTL was measured as a biomarker for the redox status. Since
epidemiological studies usually require a high throughput of samples,
we have focused on biomarkers that can be measured on an auto-
analyzer. Some of these biomarkers, such as the ROM and TTL in
serum, have proven their value recently in large epidemiological
studies [15-18]. Although the biomarkers of total antioxidant status
are prone to some criticism recently [19], we have included a number
of these biomarkers also to investigate their mutual correlation with
and without the influence of smoking.
It was found that the oxidative stress biomarkers ROM and TOS
showed an increase of 13.8 and 4.9 % in smokers vs non-smokers. Two
other studies found also a small, but statistically significant increase in
ROM [15,16]. In these studies the absolute increase of ROM as a
consequence of smoking was not given because ROM was part of an
integrated parameter of oxidative stress, the oxidative index. On the
other handc Kotani et al. [20] and Keretetse et al. [21] did not find a
relation of ROM with smoking behavior. For the TOS assay no data
have been reported in literature.
The levels of the three antioxidant biomarkers (BAP, FRAP and
TAS) decreased with smoking but to a smaller percentage compared to
the increase of ROM. Also uric acid decreased by 10.6 % in smokers.
Since uric acid is the main determinant of the antioxidant assays in
serum or plasma [22], it could be expected that the assays for the
antioxidant status also would measure lower values. In a recent paper
[23], we reported the correlation coefficients of uric acid with BAP,
FRAP, TAS and OXY. FRAP and TAS showed the highest correlation
coefficient of 0.869 and 0.922, respectively. BAP and OXY showed
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much lower correlation coefficients of 0.302 and 0.272, respectively.
The 10.6 % decrease of UA in smokers, however, is not reflected in the
decrease of FRAP (3.6 %) and TAS assay (6.1%). The loss of some
correlation of TAS and OXY with some other biomarkers of
antioxidant status as a result of smoking, remained to be explained.
Our study indicates once more that smokers have elevated
concentration of oxidative stress biomarkers and also a compromised
antioxidant status. Therefore, in biomarker-driven studies correction
for smoking should be taken in account as a modifying factor on
biomarkers of oxidative stress and antioxidant status. The redox status
seems to be less sensitive to smoking.
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